Completed

NCT Number: NCT05160844

SIRT1 Gene Polymorphism With Premature Myocardial Infarction in Young Egyptian Patients

This is an observertional study aimed at Study the association of SIRT1(rs7069102 ) Gene polymorphism with premature myocardial infarction in young Egyptian patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Premature Myocardial Infarction in Young Egyptian Patients

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag uniersity hosoital

Sohag, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patient with recent MI admitted to Sohag University Hospital , CCU under 40 years

Exclusion criteria

patients above 40 year old.
Patients with malignancies, major trauma or surgery in the previous six months, and acute or chronic infectious disease

Treatment and study plan

Primary outcomes

Endothelial nitric oxide synthase level

Time frame: 6 months

detect the serum level of Endothelial nitric oxide synthase by ELIZA in nanogram per millilitre (ng/ml)
SIRT1 Genotyping

Time frame: 6 months

whether homgenetic or heterogenetic

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Association of SIRT1(rs7069102 ) Gene Polymorphism With Premature Myocardial Infarction in Young Egyptian Patients

Acronym: SIRT1

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2024
First posted: Dec 16, 2021
Registry last updated: Jul 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.